Financials
- Market Capitalization 8.44 M
- Employee 8
- Founded 2011
- CEO Paul Kang
- Website www.exicuretx.com
- Headquarter Delaware, United States
- FIGI BBG00GTJCSB4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.86
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4797 | TRAW Traws Pharma, Inc. - Common Stock | 0.59 USD | 0.00% | +5.36% | +20.41% | -55.97% | 9.07 M USD | ||
| 4800 | IMNN Imunon, Inc. - Common Stock | 1.60 USD | 0.00% | -1.84% | -5.33% | -50.77% | 8.98 M USD | ||
| 4814 | SNGX Soligenix, Inc. - Common Stock | 0.38 USD | 0.00% | -7.32% | +2.70% | -66.37% | 8.27 M USD | ||
| 4817 | CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.52 USD | 0.00% | -3.16% | +13.81% | -10.97% | 8.07 M USD |